Monthly Archives - August 2017

Corbus Pharmaceuticals to Present New Data from Systemic Sclerosis Phase 2 Study of Anabasum at the 15th International Workshop on Scleroderma Research

Corbus Pharmaceuticals Holdings, Inc.(NASDAQ: CRBP) (“Corbus” or the “Company”), a clinical stage drug development company targeting rare, chronic, serious inflammatory and fibrotic diseases, announced today that recently analyzed skin biopsy histology data from its Phase 2 study of anabasum for the treatment of diffuse cutaneous systemic sclerosis will be presented at the 15th International Workshop on Scleroderma Research. Read more >>

Blind man, 51, watches his football team for the first time in 27 years thanks to pioneering glasses technology only to see them get thrashed 5-1

Brian Casey, 51, wears a groundbreaking visual aid technology called eSight
He went to watch Fleetwood Town for the first time only to see them thrashed 5-1
Mr Casey is the first legally blind person in Europe to wear the high tech glasses
They work by showing a live video feed directly in front of the user’s eyes

Read more >>

Myomo, Inc. Obtains CE Mark Approval for MyoPro®

Myomo, Inc. (NYSE MKT:MYO) (“Myomo” or the “Company”), a commercial stage medical robotics company, today announced that it has obtained CE Mark approval for commercial sale of its next-generation MyoPro myoelectric arm orthosis across the European Economic Area (EEA). The CE Mark indicates MyoPro complies with the essential requirements of relevant EU legislation and has achieved quality system certification. MyoPro is the only lightweight wearable device that can restore function in the paralyzed or weakened arms and hands of […]